PPAR-γ agonist pioglitazone and the risks of malignancy among type2 diabetes mellitus patients

Research output: Contribution to journalJournal Article peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'PPAR-γ agonist pioglitazone and the risks of malignancy among type2 diabetes mellitus patients'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science